116 related articles for article (PubMed ID: 1586340)
21. Measurements of salivary progesterone throughout the menstrual cycle in women suffering from unexplained infertility reveal high frequency of luteal phase defects.
Vuorento T; Hovatta O; Kurunmäki H; Ratsula K; Huhtaniemi I
Fertil Steril; 1990 Aug; 54(2):211-6. PubMed ID: 2116329
[TBL] [Abstract][Full Text] [Related]
22. The use of human menopausal and chorionic gonadotropins for induction of ovulation. Sixteen years' experience at the Sloane Hospital for Women.
Schwartz M; Jewelewicz R; Dyrenfurth I; Tropper P; Vande Wiele RL
Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 1):801-7. PubMed ID: 6778212
[TBL] [Abstract][Full Text] [Related]
23. Combined bromocryptine and hMG treatment in hyperprolactinemic infertility.
Katz Z; Borenstein R; Lancet M
Int J Fertil; 1981; 26(4):290-2. PubMed ID: 6120912
[TBL] [Abstract][Full Text] [Related]
24. The effect of different doses of human chorionic gonadotrophin in the treatment of anovulation with human gonadotrophins.
Starup J; Sele V
Acta Endocrinol (Copenh); 1972 Nov; 71(3):469-79. PubMed ID: 4678196
[No Abstract] [Full Text] [Related]
25. The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease.
Wang CF; Gemzell C
Fertil Steril; 1980 May; 33(5):479-86. PubMed ID: 6768596
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of short-term gonadotrophin-releasing hormone agonists versus human chorionic gonadotrophin to enable oocyte release in gonadotrophin stimulated cycles.
Check JH; Nazari A; Barnea ER; Weiss W; Vetter BH
Hum Reprod; 1993 Apr; 8(4):568-71. PubMed ID: 8501187
[TBL] [Abstract][Full Text] [Related]
27. Plasma hormones in human gonadotropin induced ovulation.
Wu CH
Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
[TBL] [Abstract][Full Text] [Related]
28. Proceedings: Plasma oestradiol and progesterone estimations in the monitoring of the induction of ovulation by human menopausal gonadotrophin and human chorionic gonadotrophin.
McGarrigle HH; Radwanska E; Little V; Swyer GI
J Endocrinol; 1974 May; 61(2):LXXXI-LXXXII. PubMed ID: 4835931
[No Abstract] [Full Text] [Related]
29. [Selection criteria for the treatment with HMG + HCG in sterile patients (author's transl)].
Portuondo JA; Matia JC; Echanojauregui AD; Rementeria AM
Rev Esp Obstet Ginecol; 1978; 37(238):354-61. PubMed ID: 362494
[No Abstract] [Full Text] [Related]
30. Preliminary report about a modified gonadotropin (human menopausal gonadotropin/human chorionic gonadotropin) treatment in infertile patients with premature luteinization.
Zimmermann R; Bohnet HG; Weise HC; Leidenberger FA
Fertil Steril; 1984 May; 41(5):714-8. PubMed ID: 6425086
[TBL] [Abstract][Full Text] [Related]
31. [Progress in sterility therapy. Gonadotropin treatment, monitoring follicle maturation using real-time ultrasonics].
Schmidt W; von Holst T
Fortschr Med; 1981 Jul; 99(27-28):1080-6. PubMed ID: 6790397
[TBL] [Abstract][Full Text] [Related]
32. Early detection of multiple gestations following hMG-hCG therapy by ultrasonography and midluteal phase progesterone determinations.
Tanaka T; Sakuragi N; Fujimoto S; Ichinoe K; Mizoe J
Int J Fertil; 1983; 28(3):184-7. PubMed ID: 6140241
[TBL] [Abstract][Full Text] [Related]
33. Risk of a second consecutive first-trimester spontaneous abortion in women who conceive with menotropins.
Corsan GH; Kemmann E
Fertil Steril; 1990 May; 53(5):817-21. PubMed ID: 2110074
[TBL] [Abstract][Full Text] [Related]
34. Observations on 320 infertile patients treated with human gonadotropins (human menopausal gonadotropin/human chorionic gonadotropin).
Tsapoulis AD; Zourlas PA; Comninos AC
Fertil Steril; 1978 May; 29(5):492-5. PubMed ID: 668927
[TBL] [Abstract][Full Text] [Related]
35. Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism.
Kirk JM; Savage MO; Grant DB; Bouloux PM; Besser GM
Clin Endocrinol (Oxf); 1994 Jul; 41(1):57-63. PubMed ID: 7914153
[TBL] [Abstract][Full Text] [Related]
36. Luteinizing hormone bioactivity in human menopausal gonadotropin/human chorionic gonadotropin-induced cycles.
Abuzeid MI; Yeoman R; Aksel S
Fertil Steril; 1987 Feb; 47(2):238-43. PubMed ID: 3102284
[TBL] [Abstract][Full Text] [Related]
37. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
Yuen BH; Sy L; Cannon W
Am J Obstet Gynecol; 1981 Jul; 140(6):629-35. PubMed ID: 6167169
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome: a randomized, double-blind, placebo controlled trial.
Homburg R; Levy T; Ben-Rafael Z
Hum Reprod; 1995 Oct; 10(10):2550-3. PubMed ID: 8567768
[TBL] [Abstract][Full Text] [Related]
39. [Anovulatory sterility. Treatment with human menopausal gonadotropin and human chorionic gonadotropin].
Espersen T; Møller J; Hansen KP
Ugeskr Laeger; 1984 Feb; 146(9):640-3. PubMed ID: 6424295
[No Abstract] [Full Text] [Related]
40. Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries.
Homburg R; Eshel A; Kilborn J; Adams J; Jacobs HS
Hum Reprod; 1990 Jan; 5(1):32-5. PubMed ID: 2108981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
